News
Latest Features
Dr. Peter AttiaMedicare Advantage in Rural Counties for 2027
Medicare Advantage plan availability varies widely by county in 2027. Learn how insurer participation and provider networks may affect choices for older adults in rural US areas, with guidance on comparing options.
18/11/20266 min read
Dr. Peter AttiaFDA Guidance on IVD Validation for Emerging Pathogens 2026
FDA finalized November 2026 guidance on validating certain IVDs for emerging pathogens during Section 564 emergencies. Learn recommendations for test developers, clinical performance, and analytical validation to support public health readiness.
18/11/20266 min read
Dr. Peter AttiaFDA Class II Nasal Congestion Device 2026
FDA classified the external mechanical stimulator for nasal congestion relief as a Class II device in November 2026. Learn what this means for oversight, special controls, 510(k) requirements, and consumer considerations.
18/11/20266 min read